In order to further confirm the regulation of GIPR on pain and anxiety, GIPR antagonist Pro3-GIP was simultaneous intraperitoneally injected at a dose of 50 nM/kg once daily for 10 days. The gene discussed is GIPR; the disease is Anxiety.